KEVZARA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0024-5908 -
Package NDC
0024-5908-01 -
Package NDC
0024-5908-02 -
Application number
BLA761037 -
SPL ID
b1eeca31-be2b-4c68-a7c0-220256a2b906 -
SPL set ID
827bc01c-d379-4266-a18c-c7f904b76af3 -
UNII
NU90V55F8I -
RxCUI
1923333 -
RxCUI
1923338 -
RxCUI
1923345 -
RxCUI
1923347 -
RxCUI
2003755 -
RxCUI
2003757 -
RxCUI
2003766 -
RxCUI
2003767
What the source publishes
- Labeler
- Sanofi-Aventis U.S. LLC
- Active ingredients
- sarilumab
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "KEVZARA",
"splId": "b1eeca31-be2b-4c68-a7c0-220256a2b906",
"labels": [
{
"setId": "827bc01c-d379-4266-a18c-c7f904b76af3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=827bc01c-d379-4266-a18c-c7f904b76af3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=827bc01c-d379-4266-a18c-c7f904b76af3"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Sanofi-Aventis U.S. LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 SYRINGE in 1 PACKAGE (0024-5908-01) / 1.14 mL in 1 SYRINGE (0024-5908-00)",
"package_ndc": "0024-5908-01",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20170522"
},
{
"sample": false,
"description": "2 SYRINGE in 1 PACKAGE (0024-5908-02) / 1.14 mL in 1 SYRINGE",
"package_ndc": "0024-5908-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20170522"
}
],
"productId": "0024-5908_b1eeca31-be2b-4c68-a7c0-220256a2b906",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0024-5908",
"deaSchedule": null,
"genericName": "sarilumab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SARILUMAB",
"strength": "150 mg/1.14mL"
}
],
"applicationNumber": "BLA761037",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170522",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000190478",
"N0000190480"
],
"unii": [
"NU90V55F8I"
],
"rxcui": [
"1923333",
"1923338",
"1923345",
"1923347",
"2003755",
"2003757",
"2003766",
"2003767"
],
"spl_set_id": [
"827bc01c-d379-4266-a18c-c7f904b76af3"
],
"pharm_class_epc": [
"Interleukin-6 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Interleukin 6 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Sanofi-Aventis U.S. LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0024-5908_b1eeca31-be2b-4c68-a7c0-220256a2b906"